NuVasive's latest FDA approval, Bioventus' $45M acquisition & more: 6 device company notes

Spinal Tech

Here are six updates from spine and orthopedic device companies over the past week:

1. Durham, N.C.-based medical technology company Bioventus acquired rehabilitation solutions company Bioness for $45 million upfront consideration, with up to $65 million contingent consideration. 

2. Spinal implant manufacturer SeaSpine on April 1 added Shweta Singh Maniar to its board of directors. 

3. SeaSpine shared its preliminary financial report for the first quarter.

4. The 9th U.S. Circuit Court of Appeals revived a lawsuit April 2 accusing Medtronic of violating the False Claims Act by misrepresenting select spine devices to the FDA for clearance.

5. The FDA approved NuVasive's Simplify cervical artificial disc for two-level total disc replacement.

6. Ron Matricaria, chair of the Orthofix board of directors since 2014, will not seek reelection at the company's 2021 annual meeting.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers